URose Hip

-Delile

• Kungenzeka kusebenze ...
• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

I-rose hip yingxenye eyindilinga yembali ye-rose engezansi kwezimbali. I-rose hip iqukethe imbewu yesitshalo se-rose. Isinqe se-rose esomile futhi imbewu isetshenziswa ndawonye ukwenza umuthi.

I-rose rose hip iqukethe uvithamini C, ngakho-ke abanye abantu bayithatha njengomthombo kavithamini C. Kodwa-ke, uvithamini C omningi okwi-rose hip uyacekelwa phansi ngesikhathi somiswa nokucubungulwa. I-rose hip isetshenziselwa i-osteoarthritis nobuhlungu ngemuva kokuhlinzwa. Isetshenziselwa nezinye izimo eziningi, kepha abukho ubufakazi obuhle besayensi bokuxhasa lokhu okunye ukusetshenziswa.

Ekudleni nasekukhiqizeni, i-rose hip isetshenziselwa itiye, ujamu, isobho, futhi njengomthombo wemvelo kavithamini C.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze ROSE HIP zimi kanje:

Kungenzeka kusebenze ...

• I-osteoarthritis. Iningi locwaningo lubonisa ukuthi ukuthatha i-rose hip ngomlomo kunganciphisa ubuhlungu nokuqina futhi kuthuthukise ukusebenza kubantu abane-osteoarthritis.
• Ubuhlungu ngemuva kokuhlinzwa. Olunye ucwaningo lubonisa ukuthi ukuthatha umthamo owodwa we-rose hip akhiphe ngokushesha ngaphambi kwesigaba se-C kusiza ukunciphisa ubuhlungu kanye nesidingo semithi yezinhlungu ngemuva kokuhlinzwa.

Ubufakazi obanele bokukala ukusebenza kwe ...

• Isikhumba esiguga. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-rose hip powder kusiza ukunciphisa imibimbi futhi kuthuthukise ikhwalithi yesikhumba kubantu abadala asebekhulile.
• Izikhukhula zokuya esikhathini (i-dysmenorrhea). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-rose hip extract kungasiza ekunciphiseni ubuhlungu obuvela ezinkalweni zokuya esikhathini.
• Ukukhuluphala ngokweqile. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-rose hip powder exutshwe nejusi le-aphula akuthinti isisindo noma amazinga kashukela egazini kubantu abakhuluphele ngokweqile. Kepha kungehlisa kancane i-cholesterol nomfutho wegazi.
• Isifo samathambo (RA). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-rose hip ngomlomo kuthuthukisa ezinye izimpawu ze-RA.
• Ukutheleleka kwezinso, isinye, noma i-urethra (izifo ezithinta umchamo noma ama-UTIs). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-rose hip powder ngemuva kwesigaba se-C kungehlisa amathuba okuba namagciwane asemgwaqeni we-urinary. Kodwa akubonakali kuvimbela izimpawu ze-UTI.
• Izinkinga zocansi ezivimbela ukwaneliseka ngesikhathi socansi.
• Ukumanzisa embhedeni.
• Ukuqinisa amasosha omzimba.
• Umdlavuza.
• Umkhuhlane ovamile.
• Isifo sikashukela.
• Uhudo.
• I-prostate ekhulisiwe (i-benign prostatic hyperplasia noma i-BPH).
• Imfiva.
• Umkhuhlane (umkhuhlane).
• Gout.
• Umfutho wegazi ophezulu.
• Izinga eliphakeme le-cholesterol noma amanye amafutha (lipids) egazini (hyperlipidemia).
• Izifo.
• Ubuhlungu ngenxa yengcindezi kwi-sciatic nerve (sciatica).
• Izinkinga zangasese noma zesibeletho.
• Izinkinga zesisu namathumbu.
• Amamaki wokunweba.
• Ukushoda kuka-Vitamin C.
• Ezinye izimo.

Kudingeka ubufakazi obuningi ukukala i-rose hip ngalokhu kusetshenziswa.

Abanye abantu basebenzisa i-rose hip njengomthombo kavithamini C. Kuyiqiniso ukuthi i-rose rose hip iqukethe uvithamini C. Kodwa ukucutshungulwa nokomiswa kwesitshalo kubulala amavithamini C. amaningi Ngaphandle kwe-vitamin C, amanye amakhemikhali emvelo atholakala ku-rose hip ilusizo ezimeni ezahlukahlukene zezempilo.

Lapho ithathwa ngomlomo: I-rose hip ekhishwe ngu CISHE UVIKILE lapho ithathwa ngamanani atholakala ekudleni. I-rose hip evela kuRosa canina nayo CISHE UVIKILE uma isetshenziswe ngokufanele ngamanani amakhulu, okwelapha. I-rose hip eqhamuka kuRosa damascena ngu OKUNGENZEKA UKUPHEPHA lapho ithathwa ngokufanele ngamanani amakhulu, okwelapha. Akukho mininingwane ethembekile yokwazi ukuthi i-rose hip kusuka kwezinye izinhlobo zama-rose iphephile ngamanani amakhulu, okwelapha. I-rose hip ingadala imiphumela emibi efana nohudo nokukhathala.

Lapho isetshenziswa esikhunjeni: Alukho ulwazi olwanele olunokwethenjelwa ukwazi ukuthi i-rose hip iphephile noma yini imiphumela emibi engaba yiyo.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Alukho ulwazi olwanele olunokwethenjelwa ukwazi ukuthi i-rose hip iphephile yini ukuyisebenzisa njengomuthi lapho ukhulelwe noma uncelisa ibele. Hlala ohlangothini oluphephile bese unamathela enanini lokudla.

Amatshe ezinso: Ngemithamo emikhulu, i-rose hip ingakhuphula ithuba lokuthola amatshe ezinso. Lokhu kungenxa yevithamini C ku-rose hip.

Maphakathi

Qaphela ngale nhlanganisela.

I-Aluminium

I-Aluminium itholakala kuma-antacid amaningi. Izinqe ezinama-rose ziqukethe uvithamini C. U-Vitamin C angakhuphula ukuthi ingakanani i-aluminium etholwa ngumzimba. Kepha akucaci ukuthi lokhu kusebenzisana kuyinkinga enkulu yini. Thatha i-rose hip amahora amabili ngaphambi noma amahora amane ngemuva kwama-antacids.

Ama-Estrogens

I-rose hip iqukethe uvithamini C. U-Vitamin C angakhuphula ukuthi umzimba umunca malini i-estrogen. Ukuthatha i-rose hip kanye ne-estrogen kungakhuphula imiphumela kanye nemiphumela emibi yama-estrogens.

Amanye amaphilisi e-estrogen afaka phakathi ama-equine estrogens ahlanganisiwe (Premarin), i-ethinyl estradiol, i-estradiol namanye.

ILithium

I-rose hip ingaba nomthelela njengephilisi lamanzi noma i- "diuretic." Ukuthatha i-rose hip kunganciphisa ukuthi umzimba ususa kanjani i-lithium. Lokhu kungakhuphula ukuthi ingakanani i-lithium esemzimbeni futhi kuholele emiphumeleni emibi kakhulu. Khuluma nomhlinzeki wakho wezokunakekelwa kwempilo ngaphambi kokusebenzisa lo mkhiqizo uma uthatha i-lithium. Umthamo wakho we-lithium ungadinga ukuguqulwa.

Imithi yomdlavuza (Ama-Alkylating agents)

I-rose hip iqukethe i-vitamin C, eyi-antioxidant. Kukhona ukukhathazeka okuthile kokuthi ama-antioxidants anganciphisa ukusebenza kweminye imithi esetshenziselwa umdlavuza. Kepha kuseduze kakhulu ukuthi wazi ukuthi lokhu kuhlangana kuyenzeka yini.

Eminye yale mithi ifaka i-cyclophosphamide, i-chlorambucil (i-Leukeran), i-carmustine (i-Gliadel), i-busulfan (i-Myleran), i-thiotepa (i-Tepadina) neminye.

Imithi yomdlavuza (Antitumor antibiotics)

I-rose hip iqukethe i-vitamin C eyi-antioxidant. Kukhona ukukhathazeka okuthile kokuthi ama-antioxidants anganciphisa ukusebenza kweminye imithi esetshenziselwa umdlavuza. Kepha kuseduze kakhulu ukuthi wazi ukuthi lokhu kuhlangana kuyenzeka yini.

Eminye yale mithi ihlanganisa i-doxorubicin (Adriamycin), i-daunorubicin (i-DaunoXome), i-epirubicin (i-Ellence), i-mitomycin (i-Mutamycin), i-bleomycin (i-Blenoxane) neminye.

Imithi eyehlisa ukunqamuka kwegazi (Anticoagulant / Antiplatelet drug)

I-rose hip iqukethe ikhemikhali engadala ukuthi igazi livale. Ukuthatha i-rose hip kanye nemithi eyehlisa kancane ukuvimba kunganciphisa ukuthi isebenza kanjani le mithi.

Eminye imithi eyehlisa ijubane ukuvala igazi ifaka i-aspirin, i-clopidogrel (i-Plavix), i-dalteparin (i-Fragmin), i-enoxaparin (i-Lovenox), i-heparin, i-ticlopidine (i-Ticlid), i-warfarin (i-Coumadin) neminye.

I-Warfarin (Coumadin)

I-Warfarin (i-Coumadin) isetshenziselwa ukunciphisa ukubamba kwegazi. I-rose hip iqukethe uvithamini C. Inani elikhulu likavithamini C lehlisa ukusebenza kwe-warfarin (Coumadin). Ukwehlisa ukusebenza kwe-warfarin (i-Coumadin) kungakhuphula ithuba lokujiya. Qiniseka ukuthi uhlolwa igazi lakho njalo. Umthamo we-warfarin yakho (i-Coumadin) ungadinga ukuguqulwa.

Okuncane

Qaphela ngale nhlanganisela.

I-Aspirin

I-Aspirin isuswa emzimbeni osemchameni. Abanye ososayensi baphakamise ukukhathazeka ngokuthi uvithamini C wehlise ukuthi i-aspirin ekhishwa kangakanani emchameni. I-rose hip iqukethe uvithamini C Kunokukhathazeka ngokuthi ukuthatha i-rose hip kungakhuphula amathuba emiphumela emibi ehlobene ne-aspirin. Kepha ucwaningo luphakamisa ukuthi lokhu akuyona into ebalulekile, nokuthi uvithamini C ku-rose hip akahlangani ngendlela ezwakalayo ne-aspirin.

I-Acerola

I-rose hip ne-acerola zombili ziqukethe amazinga aphezulu kavithamini C. Ungathathi womabili ndawonye. Lokhu kungakunika uvithamini C omningi kakhulu. Abantu abadala akumele bathathe ngaphezu kuka-2000 mg kavithamini C ngosuku.

Uvithamini C

I-rose hip iqukethe uvithamini C. Ukuthatha i-rose hip enezithasiselo zikavithamini C kungandisa amathuba okuba nemiphumela engemihle evela ku-vitamin C. Abantu abadala akufanele bathathe ngaphezu kuka-2000 mg kavithamini C ngosuku.

Akukho ukuxhumana okwaziwayo nokudla.

Imithamo elandelayo ifundwe ocwaningweni lwesayensi:

ABADALA
NGOMLOMO:

• Okwe-osteoarthritis: 2.5 amagremu we-rose hip powder (LitoZin / i-flex, iHyben Vital) ithathwe kabili nsuku zonke izinyanga ezi-3. I-40 mL yomkhiqizo ohlanganisiwe othize oqukethe i-rose hip izithelo puree 24 gram, neting netting 160 mg, devil's claw 108 mg ne-vitamin D 200 IU (Rosaxan, Medagil Gesundheitsgesellschaft) ithathwe nsukuzonke izinyanga ezintathu.
• Yezinhlungu ngemuva kokuhlinzwa: 1.6 amagremu we-rose extract athathwe imizuzu eyi-15 ngaphambi kokuhlinzwa.

Apothecary Rose, Cherokee Rose, Cherokee Rose Musquée, Chinese Rosehip, Cynorhodon, Cynorhodons, Cynosbatos, Damask Rose, Dog Rose, Dog Rose Hips, Églantier, Fructus Rosae Laevigatae, Fruit de l'Églantier, Gulab, Heps, Hip, isithelo se-Hip I-Hip Sweet, i-Hipberry, i-Hop Fruit, i-Jin Yin Zi, i-Jinyingzi, i-Persian Rose, i-Phool Gulab, i-Pink Rose, i-Poire d'oiseaux, i-Provence Rose, i-Rosa alba, i-Rosa canina, i-Rosa centifolia, i-Rosa cherokeensis, i-Rosa chinensis, i-Rosa damascena, i-Rosa de Castillo, Rosa gallica, Rosa laevigata, Rosa lutetiana, Rosa moschata, Rosa mosqueta, Rosa Mosqueta Cherokee, Rosa pomifera, Rosa provincialis, Rosa rubiginosa, Rosa rugosa, Rosa villosa, Rosae Pseudofructus Cum Semen, Rose de Provinsai, Rose des Apothic, Rose des Apothic URose Haw, uRose Hep, uRose Hips, uRose Rouge de Lancaster, uRosehip, uRosehips, uRosier de Provence, uRosier des Cherokees, Satapatri, Satapatrika, Shatpari, White Rose, Izithelo Zengulube Zasendle.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. I-Phetcharat L, i-Wongsuphasawat K, i-Winther K. Ukusebenza kwempuphu ye-rose ye-rose, equkethe imbewu namagobolondo kaRosa canina, esikhathini eside samaseli, imibimbi yesikhumba, umswakama, nokunwebeka. Ukuguga Kwe-Clin Interv. 2015; 10: 1849-56. Buka okungaqondakali.
2. I-Mostafa-Gharabaghi ​​P, Delazar A, Gharabaghi ​​MM, Shobeiri MJ, Khaki A. Umbono wezinhlungu zokuhlinzwa ngemuva kokusebenzisa ngaphambi kokukhishwa kweRosa damascena kwabesifazane abanesigaba sokukhetha sokuhlinzwa. Umhlaba Sci J. 2013; 4: 226-35.
3. Bani S, Hasanpour S, Mousavi Z, Mostafa Garehbaghi ​​P, Gojazadeh M. Umphumela kaRosa damascena okhishwe kwi-dysmenorrhea eyinhloko: Isivivinyo somtholampilo esiphambuka kabili. I-Iran Red Crescent Med J. 2014; 16: e14643. Buka okungaqondakali.
4. UMármol I, uSánchez-de-Diego C, uJiménez-Moreno N, u-Ancín-Azpilicueta C, uRodríguez-Yoldi MJ. Izicelo zokwelashwa zama rose rose ezivela ezinhlotsheni ezahlukahlukene zeRosa. Int J Mol Sci. 2017; 18: 1137. Buka okungaqondakali.
5. Jiang K, Tang K, Liu H, Xu H, Ye Z, Chen Z. Ascorbic acid supplements kanye nezinso zamatshe izehlakalo phakathi kwabesilisa nabesifazane: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta. Urol J. 2019; 16: 115-120. Buka okungaqondakali.
6. UCesarone MR, uBelcaro G, uSpipione C, et al. Ukuvimbela ukoma kwesitho sangasese sowesifazane kwabesifazane be-perimenopausal. Ukwengezwa ngeLady Prelox®. UMinerva Ginecol. 2019; 71: 434-41. Buka okungaqondakali.
7. Seifi M, Abbasalizadeh S, Mohammad-Alizadeh-Charandabi S, Khodaie L, Mirghafourvand M. Umphumela kaRosa (L. Rosa canina) esehlakalweni sokutheleleka ngomgudu womchamo e-puerperium: isilingo esilawulwa ngokungahleliwe. I-Phytother Res 2018; 32: 76-83. Buka okungaqondakali.
8. UMoré M, uGruenwald J, Pohl U, Uebelhack R. I-Rosa canina - urtica dioica - harpagophytum procumbens / zeyheri inhlanganisela inciphisa kakhulu izimpawu ze-gonarthritis esifundweni esilawulwa ngokungahleliwe, esilawulwa yi-placebo esilawulwa kabili. IPlanta Med 2017; 83: 1384-91. Buka okungaqondakali.
9. UGarcía Hernández JÁ, Madera González D, Padilla Castillo M, Figueras Falcón T. Ukusetshenziswa kokhilimu wokumaka othize wokuvikela noma ukunciphisa ubunzima be-striae gravidarum. Isivivinyo esilawulwa ngokungahleliwe, esiyimpumputhe, I-Int J Cosmet Sci. 2013; 35: 233-7. Buka okungaqondakali.
10. UBottari A, uBelcaro G, uLedda A, et al. ILady Prelox ithuthukisa ukusebenza kocansi kubantu besifazane abanempilo yobudala bokuzala. UMinerva Ginecol 2013; 65: 435-44. Buka okungaqondakali.
11. I-Oprica L, iBucsa C, iZamfiranche MM. Okuqukethwe kwe-Ascorbic acid kwezithelo ze-rose hip kuye ngobude. I-Iran J Impilo Yomphakathi 2015; 44: 138-9. Buka okungaqondakali.
12. UFresz T, uNagy E, uHilbert A, uTomcsanyi J. Indima yama-flavonoids kuzilingo ezingamanga ezingamanga ezibangelwa ukusetshenziswa kwembali ye-hibiscus ne-rose tea tea. I-Int J Cardiol 2014; 171: 273-4. Buka okungaqondakali.
13. UVan Steirteghem AC, uRobertson EA, iDys DS. Ithonya lamanani amakhulu we-ascorbic acid emiphumeleni yokuhlolwa kwelabhoratri. Umtholampilo Chem. 1978; 24: 54-7. Buka okungaqondakali.
14. UWinther, K. noKharazmi, A. Impuphu elungiselelwe kusuka ezimbewini nasemagobolondweni e-rose-hip Rosa canina kunciphisa ubuhlungu ezigulini ezine-osteoarthritis yesandla - isifundo esilawulwa nge-placebo esiphindwe kabili. I-Osteoarthr Cartil 2004; 12 (iSuppl 2): ​​145.
15. URein, E., Kharazmi, A., Thamsborg, G., noWinther, K. Ikhambi lamakhambi elenziwe ngama-subspecies e-rose-hip Rosa canina linciphisa izimpawu zamadolo nezinyonga ze-osteoarthritis. I-Osteoarthr Cartil 2004; 12 (iSuppl 2): ​​80.
16. UWarholm, O., Skaar, S., Hedman, E., Molmen, HM, no-Eik, L. Imiphumela yekhambi elenziwe ngamakhambi lisuselwa kuhlobo oluthile lweRosa canina ezigulini ezine-osteoarthritis: impumputhe kabili, engahleliwe, isilingo somtholampilo esilawulwa yi-placebo. ICurr Ther Res 2003; 64: 21-31.
17. Ma, YX, Zhu, Y., Wang, CF, Wang, ZS, Chen, SY, Shen, MH, Gan, JM, Zhang, JG, Gu, Q., no-He, L. Umphumela wokuguga wokulibala -Ukuphila CiLi '. IMech. Ukuguga kwe-Dev 1997; 96 (1-3): 171-180. Buka okungaqondakali.
18. UTeng, C. M., Kang, Y. F., Chang, Y. L., Ko, F. N., Yang, S. C., noHsu, F. L. ADP-balingisa ukuhlanganiswa kweplatelet okubangelwa yi-rugosin E, i-ellagitannin ehlukaniswe neRosa rugosa Thunb. Ukuhlanya. 1997; 77: 555-561. Buka okungaqondakali.
19. UDushkin, M. I., Zykov, A. A., noPivovarova, E. N. [Umphumela wezinhlanganisela zemvelo ze-polyphenol ekuguqulweni kwe-oxidative kwama-lipoprotein asezingeni eliphansi]. I-Biull.Eksp. Biol Med 1993; 116: 393-395. Buka okungaqondakali.
20. UShabykin, G. P. noGodorazhi, A. I. [Ukulungiswa kwe-polyvitamin kwamavithamini ancibilikayo anamafutha (carotolin) kanye namafutha okhalweni ekwelapheni ama-dermatoses athile]. I-Vestn.Dermatol.Venerol. Ngo-1967; 41: 71-73. Buka okungaqondakali.
21. UMoreno Gimenez, J. C., Bueno, J., Navas, J., noCamacho, F. [Ukwelashwa kwesilonda sesikhumba kusetshenziswa uwoyela we-mosqueta rose]. UMed Cutan. Ibero. Ngo-1990; 18: 63-66. Buka okungaqondakali.
22. UHan SH, uHur MH, uBuckle J, et al. Umphumela we-aromatherapy ezinkomba ze-dysmenorrhea kubafundi basekolishi: Isivivinyo somtholampilo esilawulwa ngokungahleliwe. J Altern Complement Med 2006; 12: 535-41. Buka okungaqondakali.
23. UChrubasik, C., Duke, R. K., noChrubasik, S. Ubufakazi bokusebenza kahle kwemitholampilo ye-rose hip nembewu: ukubuyekeza okuhlelekile. I-Phytother Res 2006; 20: 1-3. Buka okungaqondakali.
24. UWinther, K., Apel, K., noThamsborg, G. Impuphu eyenziwe ngezimbewu namagobolondo e-rose-hip subspecies (Rosa canina) inciphisa izimpawu zamadolo kanye ne-hip osteoarthritis: i-placebo elawulwa ngokungahleliwe, eyimpumputhe isilingo somtholampilo. Scand J Rheumatol. 2005; 34: 302-308. Buka okungaqondakali.
25. UJanse, van Rensburg, Erasmus, E., Loots, DT, Oosthuizen, W., Jerling, JC, Kruger, HS, Louw, R., Brits, M., no-van der Westhuizen, FH Rosa roxburghii ukwengezwa kokudla okulawulwayo ukutadisha kwandisa amandla e-plasma antioxidant kanye nesimo se-glutathione redox. I-Eur J Nutriti 2005; 44: 452-457. Buka okungaqondakali.
26. UVenkatesh, R. P., Ramaesh, K., kanye noBrowne, B. Rose-hip keratitis. Iso 2005; 19: 595-596. Buka okungaqondakali.
27. Rein, E., Kharazmi, A., noWinther, K. Ikhambi elenziwe ngamakhambi, iHyben Vital (stand. Powder of a subspecies of Rosa canina izithelo), linciphisa izinhlungu futhi lithuthukise impilo enhle ezigulini ezine-osteoarthritis - impumputhe , isilingo esilawulwa nge-placebo, esingahleliwe. I-Phytomedicine. 2004; 11: 383-391. Buka okungaqondakali.
28. ULarsen, E., Kharazmi, A., Christensen, L. P., noChristensen, S. B. An antiinfigueatory galactolipid from rose hip (Rosa canina) evimbela i-chemotaxis yegazi lomzimba elenza i-neutrophils in vitro. UJ. Nat. UProd. 2003; 66: 994-995. Buka okungaqondakali.
29. I-Basim, E. neBasim, H. Umsebenzi wama-antibacterial kaRosa damascena kawoyela obalulekile. UFitoterapia 2003; 74: 394-396. Buka okungaqondakali.
30. UDaels-Rakotoarison, DA, uGressier, B., Trotin, F., Brunet, C., Luyckx, M., Dine, T., Bailleul, F., Cazin, M., noCazin, Imiphumela yeJC yezithelo zeRosa canina kukhishwe ekuqhumeni kokuphefumula kwe-neutrophil. I-Phytother.Res. 2002; 16: 157-161. Buka okungaqondakali.
31. URossnagel, K. noWillich, S. N. [Inani lomuthi ohambisanayo oboniswe ngama-rose-hips]. UGesundheitswesen 2001; 63: 412-416. Buka okungaqondakali.
32. UTrovato, A., Monforte, M. T., Forestieri, A. M., noPizzimenti, F. In vitro anti-mycotic activity yezinye izitshalo zokwelapha eziqukethe i-flavonoids. IBoll Chim Farm 2000; 139: 225-227. Buka okungaqondakali.
33. Shiota, S., Shimizu, M., Mizusima, T., Ito, H., Hatano, T., Yoshida, T., noTsuchiya, T. Ukubuyiselwa kokusebenza kwama-beta-lactams kuma-methicillin-resistant Staphylococcus aureus ngu-tellimagrandin Mina kusuka rose ebomvu. I-FEMS Microbiol. Letet 4-15-2000; 185: 135-138. Buka okungaqondakali.
34. UHornero-Mendez, D. noMinguez-Mosquera, M. I. I-Carotenoid pigments ku-Rosa mosqueta hips, omunye umthombo we-carotenoid wokudla. J Agric Ukudla Chem 2000; 48: 825-828. Buka okungaqondakali.
35. I-Cho, i-EJ, i-Yokozawa, i-T, i-Rhyu, i-DY, i-Kim, i-SC, i-Shibahara, i-N., nePaki, i-JC Study ngemiphumela yokuvimbela izitshalo zokwelapha zaseKorea kanye nezinhlanganisela zazo eziyinhloko ku-1,1-diphenyl-2-picrylhydrazyl kakhulu. I-Phytomedicine. 2003; 10 (6-7): 544-551. Buka okungaqondakali.
36. UKumarasamy, Y., Cox, P. J., Jaspars, M., Nahar, L., noSarker, S. D. Imbewu yokuhlola izitshalo zaseScotland ngomsebenzi wokulwa namagciwane. UJ Ethnopharmacol 2002; 83 (1-2): 73-77. Buka okungaqondakali.
37. Biswas, N. R., Gupta, S. K., Das, G. K., Kumar, N., Mongre, P. K., Haldar, D., noBeri, S. Ukuhlolwa kwamaconsi wamehlo e-Ophthacare - ukwakheka kwamakhambi ekuphatheni kwezifo ezahlukahlukene zamehlo. I-Phytother.Res. 2001; 15: 618-620. Buka okungaqondakali.
38. UAndersson U, uBerger K, uHogberg A, et al. Imiphumela yokudla kwe-hip hip kwizimpawu zengozi yesifo sikashukela sohlobo 2 nesifo senhliziyo: uphenyo olwenziwe ngokungahleliwe, oluyimpumputhe, lokuwela kubantu abakhuluphele. I-Eur J Yomsoco Wezempilo 2012; 66: 585-90. Buka okungaqondakali.
39. UWillich SN, uRossnagel K, uRoll S, et al. URose hip ikhambi lamakhambi ezigulini ezibangelwa isifo samathambo - isilingo esilawulwa ngokungahleliwe. I-Phytomedicine 2010; 17: 87-93. Buka okungaqondakali.
40. I-Conklin KA. I-Cancer chemotherapy kanye nama-antioxidants. UJ Nutrithi 2004; 134: 3201S-3204S. Buka okungaqondakali.
41. UPrasad KN. Isizathu sokusebenzisa ama-antioxidants amaningi anezindlela eziphakeme zokudla njengesihlanganisi sokwelapha ngemisebe kanye ne-chemotherapy. UJ Nutriti 2004; 134: 3182S-3S. Buka okungaqondakali.
42. UTaylor EN, uStampfer MJ, uCurhan GC. Izici zokudla kanye nobungozi bokwenzeka kwamatshe ezinso emadodeni: ukuqonda okusha ngemuva kweminyaka eyi-14 yokulandelwa. UJ Am Soc Nephrol 2004; 15: 3225-32. Buka okungaqondakali.
43. I-Weintraub M, i-Griner PF. I-Warfarin ne-ascorbic acid: ukuntuleka kobufakazi bokusebenzisana kwezidakamizwa. I-Toxicol Appl Pharmacol 1974; 28: 53-6. Buka okungaqondakali.
44. UFetam CL, uLeach RH, uMeynell MJ. Ukuntuleka kokuxhumana okubalulekile emtholampilo phakathi kwe-warfarin ne-ascorbic acid. I-Toxicol Appl Pharmacol 1975; 31: 544-7. Buka okungaqondakali.
45. UVihtamaki T, uParantainen J, uKoivisto AM, et al. I-Oral ascorbic acid inyusa i-plasma oestradiol ngesikhathi sokwelapha i-postmenopausal therapy. IMatritas 2002; 42: 129-35. Buka okungaqondakali.
46. UHansten PD, uHayton WL. Umphumela we-antacid ne-ascorbic acid ekugxileni kwe-serum salicylate. UJ Clin Pharmacol 1980; 20: 326-31. Buka okungaqondakali.
47. UMc Leod DC, uNahata MC. Ukungasebenzi kahle kwe-ascorbic acid njenge-urifier acidifier (incwadi). N Engl J Med 1977; 296: 1413. Buka okungaqondakali.
48. UTraxer O, uHuet B, uPoindexter J, et al. Umphumela wokusetshenziswa kwe-ascorbic acid ezintweni ezinobungozi zamatshe e-urinary. J Urol 2003; 170: 397-401 .. Buka okungaqondakali.
49. USmith EC, uSkalski RJ, uJohnson GC, uRossi GV. Ukusebenzisana kwe-ascorbic acid ne-warfarin. I-JAMA 1972; 221: 1166. Buka okungaqondakali.
50. UHume R, Johnstone JM, Weyers E. Ukusebenzisana kwe-ascorbic acid ne-warfarin. I-JAMA 1972; 219: 1479. Buka okungaqondakali.
51. Ukusebenzisana kukaRosenthal G.I-ascorbic acid ne-warfarin. IJAMA 1971; 215: 1671. Buka okungaqondakali.
52. Ikhodi ye-elekthronikhi yemithethonqubo kahulumeni. Isihloko 21. Ingxenye 182 - Izinto Ngokuvamile Zaziwa Njengokuphepha. Kutholakala ku: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
53. IBhodi Yezokudla Nezokudla, Isikhungo Sezokwelapha. Ukufakwa Kwezikhombo Zezokudla ku-Vitamin C, Vitamin E, Selenium, neCarotenoids. Washington, DC: I-National Academy Press, 2000. Itholakala ku: http://www.nap.edu/books/0309069351/html/.
54. UHansten PD, Uphondo JR. Ukuhlaziywa Kokusebenzisana Kwezidakamizwa Nokuphathwa. IVancouver, WA: Applied Therapeutics Inc., 1997 nezibuyekezo.
55. U-Levine M, uRumsey SC, uDaruwala R, et al. Imigomo nezincomo zokungeniswa kukavithamini C. I-JAMA 1999; 281: 1415-23. Buka okungaqondakali.
56. ULabriola D, Livingston R. Ukusebenzisana okungenzeka phakathi kwama-antioxidants okudla kanye ne-chemotherapy. I-Oncology 1999; 13: 1003-8. Buka okungaqondakali.
57. I-DS encane. Imiphumela Yezidakamizwa Ekuvivinyweni Kwelabhoratri Yomtholampilo 4th ed. IWashington: I-AACC Press, 1995.
58. UMorris JC, Beeley L, Ballantine N. Ukusebenzisana kwe-ethinyloestradiol ne-ascorbic acid kumuntu [incwadi]. UBr Med J (Clin Res Ed) 1981; 283: 503. Buka okungaqondakali.
59. UDJ osemuva, uBreckenridge AM, uMacIver M, et al. Ukusebenzisana kwe-ethinyloestradiol ne-ascorbic acid kumuntu. UBr Med J (Clin Res Ed) 1981; 282: 1516. Buka okungaqondakali.
60. UGruenwald J, Brendler T, Jaenicke C. PDR weMithi Yemithi. 1st ed. IMontvale, NJ: I-Medical Economics Company, Inc., ngo-1998.
61. UMcEvoy GK, umhleli. Imininingwane Yezidakamizwa ze-AHFS. I-Bethesda, MD: I-American Society of Health-System Pharmacists, ngo-1998.
62. ILeung AY, Foster S. Encyclopedia Yezithako Ezivamile Zemvelo Esetshenziswa Ekudleni, Izidakamizwa Nezimonyo. Okwesibili. ENew York, NY: UJohn Wiley & Sons, 1996.
63. Wichtl MW. Izidakamizwa ze-Herbal kanye ne-Phytopharmaceuticals. Umhleli. UNM Bisset. Stuttgart: IMedpharm GmbH Scientific Publishers, 1994.
64. Ukubuyekezwa Kwemikhiqizo Yemvelo ngamaqiniso nokuqhathanisa. ISt. Louis, MO: IWolters Kluwer Co., 1999.
65. UFoster S, uTyler VE. Amakhambi Athembekile KaTyler: Umhlahlandlela Oqondakalayo Wokusetshenziswa Kwamakhambi Namakhambi Ahlobene. 3rd ed., Binghamton, NY: I-Haworth Herbal Press, ngo-1993.
66. UTyler VE. Amakhambi Okuzikhethela. IBinghamton, NY: Imikhiqizo Yemikhiqizo Yezokwelapha, 1994.
67. UBlumenthal M, u-ed. I-Complete German Commission E Monographs: Umhlahlandlela Wezokwelapha Emithini Yemithi. I-Trans. S. Klein. IBoston, MA: Umkhandlu Wezamabhodlela waseMelika, ngo-1998.
68. Ama-monographs ngokusetshenziswa kokwelashwa kwemithi yezitshalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.

Kugcine ukubuyekezwa - 01/26/2021